Liver function tests must be performed before starting treatment. Treatment must not be initiated if transaminases (ALT or AST) exceed 2 × ULN (isolated or in combination with bilirubin >2 × ULN)1
During treatment, liver function tests must be performed monthly during the first two treatment courses. For further treatment courses, liver function must be tested once before each new treatment course and when clinically indicated1
In addition liver testing should be performed 2–4 weeks after treatment has stopped1
In order to ensure that patients are adequately informed on the possible risks of liver injury and the implemented risk minimisation measures, a patient card is to be provided in each package of Esmya. Click here to download it.
ALT, alanine transaminase; AST, aspartate aminotransferase; ULN, upper limit of normal 1. ESMYA®. Summary of Product Characteristics. May 2018; 2. Donnez J, et al. Fertil Steril 2016;105:165–73.e4
Hypersensitivity to the active substance or to any of the excipients listed in section 6.1 of the Smpc.
Pregnancy and breastfeeding.
Genital bleeding of unknown aetiology or for reasons other than uterine fibroids.
Uterine, cervical, ovarian or breast cancer.
Underlying hepatic disorder.
In order to ensure that patients are adequately informed on the possible risks of liver injury and the implemented risk minimisation measures, a patient card is to be provided in each package of Esmya. Click here to download it.
The relationship between fibroid volume reduction and diameter is not linear.
Instructions for use
Move the sliders to display the required data range. The fibroid size sliders show the diameter of the fibroid in cm (original diameter in pink and the current diameter in yellow) and the percentage reduction in volume is shown in green.
An online portal for healthcare professionals managing uterine fibroids.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.AcceptRead More
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
This information contained in this website was specifically created for healthcare professionals. Please tick here to confirm that you are a licensed healthcare professional.
Registration conditions of ESMYA® could differ in each country, please refer to your local regulations for more information.